Management

Karin Wehlin

CEO since November 2023
Board Member since 2023

Learn more about her background and other engagements below.

Per Heander

CFO since 2021

Background and Education: Per Heander holds a degree in Business Administration from Lund University and has 20 years of experience as an Investment Manager in venture capital, with extensive experience in developing young growth companies and serving as a board member. Heander has served as CFO for various companies including Invent Medic, Bomill, and Benchtell AB. He also brings 10 years of experience from different positions within SEB.

Current Engagements: Board member at Gand AB, board member and CEO of Treeridge AB, and deputy board member of Fyra X Invest AB.

Holdings in the Company:
Per Heander owns 104,755 shares, of which 47,615 are through capital insurance.
Treeridge AB holds 473,677 shares.

Board

Kerstin Åkesson Jakobsson

Chair of the Board since 2023

On the board since: 2021

Background and Education: Kerstin Åkesson Jakobsson is a civil engineer with over 30 years of experience in marketing and sales, primarily in the Medtech sector, as well as in corporate management and business development. She has served as CEO for development companies such as SpectraCure AB and Ortoma AB, and CEO for Medicon Village Innovation. Jakobsson has also completed board training at EFL and the Board Academy.

Current Engagements: Senior Advisory of Kongsberg Beam Technology AS and CEO and chairman of Krakesson AB. Board member of the Stiftelsen TEM, QueenInvest AB, and OctaQuest AB.

Holdings in the Company:
Kerstin Jakobsson owns 19,045 shares.
Krakesson AB holds 240,516 shares.

Independent in relation to the Company and its management / major shareholders of the Company: Yes / No

Karin Wehlin

Board Member

On the board since: 2023

Background and Education: Karin Wehlin has an Executive MBA degree from Lunds University and educated at INSEAD in Strategy, Innovation, and Leadership. Karin has over 25 years of experience in senior positions within the Life Science sector. She has served as CEO of Respiratorius AB, LU Food Science AB, and BoMill AB, as well as a Manager in Corporate Finance. Karin is also the founder of EQL Pharma AB, where she was the executive Chairman of the board for 10 years.

Current Engagements: Chair of the Board at Duearity AB and Respiratorius AB.

Holdings in the Company:
0 shares

Independent in relation to the Company and its management / major shareholders of the Company: No / Yes

Kushagr Punyani

Board Member

On the board since: 2020

Background and Education: Kushagr Punyani is educated in microfluidics and biosensors. Punyani has co-founded several startups in the tech industry alongside his role as Chief Scientific Officer (CSO) at Spermosens AB, a company specializing in diagnostic equipment and products for male fertility diagnostics and treatment.

Current Engagements: Board member at Spermosens AB, Prolevi Bio AB and Nested Bio AB.

Holdings in the Company:
Kushagr Punyani owns 1,876,000 shares and has private capital invested in the Company.
Nested Bio AB holds 110,292 shares.

Independent in relation to the Company and its management / major shareholders of the Company: Yes / No

Edvard Hall

Board Member

On the board since: 2021

Background and Education: Edvard Hall holds degrees in economics and law and is an entrepreneur with extensive experience in building and managing companies within the sustainability sector. Hall also has a master’s degree in political economy from the London School of Economics.

Current Engagements: CEO of Bioextrax AB (publ), Chairman of the Board for ProLevi Bio AB and Könvyes Invest AB, and Board Member of Parlametric AB.

Holdings in the Company: 358,000 shares and private capital invested in the Company.

Independent in relation to the Company and its management / major shareholders of the Company: Yes / Yes

Founding Partners

Andreas Nyberg

Founding Partner

Johan Källstrand

Founding Partner

Kushagr Punyani

Tech Advisor, Founding Partner